The Art of Nanoimmunobiotechnomedicine in Depression Management

Abstract

Nanoimmunobiotechnomedicine represents a frontier for personalized depression therapies. The integration of nanotechnology and immunobiology enhances bioavailability and specificity in targeting depressive disorders at the molecular level. This convergence of molecular biology, and bioinformatics studies holds significant potential to revolutionize depression treatment, offering more effective and individualized solutions for better mental health outcomes.

Access to Document

Other files and links

• Link to publication in Scopus
• Open Access Version Available

Fingerprint